Understanding the causes of systemic sclerosis
Part of Skin clinical trials.
This study looks at how systemic sclerosis (a condition where the immune system attacks healthy tissue, causing skin and organ hardening) starts and gets worse. By understanding this, doctors hope to find better treatments. It involves regular check-ups and providing some health information.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a diagnosis of limited, limited cutaneous, or diffuse cutaneous systemic sclerosis.
- You are between 18 and 80 years old.
- You are a patient at CUSL (a hospital in Belgium) and attend regular consultations there.
- You must not have another autoimmune or autoinflammatory disease (like lupus or rheumatoid arthritis).
- You must not be pregnant.
- You must be able to give consent and read/sign the consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how scleroderma affects physical performance and daily function in children and adults. It aims to understand the impact of the disease on movement and everyday activities.
This study follows people with systemic sclerosis (a condition that causes hardening and tightening of the skin and can affect organs) to learn more about the disease over time. By joining, you help researchers understand it better, and you may get more careful monitoring.
This study looks at skin cells and immune cells in people with systemic sclerosis to better understand what drives the disease. Your participation may help researchers learn how the immune system and skin support cells change over time.
This study compares skin samples from people with scleroderma and healthy volunteers to understand what goes wrong in the skin. It may help researchers find new treatment targets.
This study is looking at people with systemic sclerosis (a condition that causes hardening and tightening of the skin and can affect internal organs) to learn more about the disease. You may join if you have been diagnosed with this condition and meet a few other requirements.
This study uses skin samples from people with scleroderma, their relatives, and healthy volunteers to create stem cells in a lab. The goal is to learn more about the disease and find better ways to treat it.
Hear when a new Scleroderma (Limited and Diffuse) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.